
Improving Financial Performance and Profits of Pharmaceutical Companies During a Pandemic: Study on Environmental Performance, Intellectual Capital and Social Responsibility
Publication year - 2021
Publication title -
quality - access to success
Language(s) - English
DOI - 10.47750/qas/22.184.20
Subject(s) - business , pandemic , intellectual capital , social responsibility , finance , covid-19 , accounting , public relations , political science , medicine , disease , pathology , infectious disease (medical specialty)